Your browser doesn't support javascript.
loading
Liver-Directed Therapies for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.
Kis, Bela; El-Haddad, Ghassan; Sheth, Rahul A; Parikh, Nainesh S; Ganguli, Suvranu; Shyn, Paul B; Choi, Junsung; Brown, Karen T.
Affiliation
  • Kis B; 1 Department of Diagnostic Imaging and Interventional Radiology, Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
  • El-Haddad G; 1 Department of Diagnostic Imaging and Interventional Radiology, Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
  • Sheth RA; 2 Department of Interventional Radiology, MD Anderson Cancer Center, Houston, TX, USA.
  • Parikh NS; 1 Department of Diagnostic Imaging and Interventional Radiology, Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
  • Ganguli S; 3 Center for Image Guided Cancer Therapy, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Shyn PB; 4 Department of Radiology, Abdominal Imaging and Intervention, Brigham and Women's, Boston, MA, USA.
  • Choi J; 1 Department of Diagnostic Imaging and Interventional Radiology, Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
  • Brown KT; 5 Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Cancer Control ; 24(3): 1073274817729244, 2017.
Article in En | MEDLINE | ID: mdl-28975829
ABSTRACT
Hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (IHC) are primary liver cancers where all or most of the tumor burden is usually confined to the liver. Therefore, locoregional liver-directed therapies can provide an opportunity to control intrahepatic disease with minimal systemic side effects. The English medical literature and clinical trials were reviewed to provide a synopsis on the available liver-directed percutaneous therapies for HCC and IHC. Locoregional liver-directed therapies provide survival benefit for patients with HCC and IHC compared to best medical treatment and have lower comorbid risks compared to surgical resection. These treatment options should be considered, especially in patients with unresectable disease.
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Chemoembolization, Therapeutic / Carcinoma, Hepatocellular / Liver Neoplasms Limits: Humans Language: En Journal: Cancer Control Journal subject: NEOPLASIAS Year: 2017 Document type: Article Affiliation country: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Chemoembolization, Therapeutic / Carcinoma, Hepatocellular / Liver Neoplasms Limits: Humans Language: En Journal: Cancer Control Journal subject: NEOPLASIAS Year: 2017 Document type: Article Affiliation country: United States